← Back to browse
HR 6993 Advanced toward a vote

Directs the Department of Veterans Affairs to award grants for randomized clinical trials of non-drug treatments for chronic mild traumatic brain injury in veterans, and authorizes $10 million per year for each of two grant programs in fiscal years 2026 through 2028.

Official title: BEACON Act of 2026

Next stop House floor: awaiting a vote
Timeline each lane is a chamber; dates pull from congress.gov actions
House
Introduced 09-JAN-2026
Referred 09-JAN-2026
Approved by committee 14-MAY-2026
Reported 01-OCT-2026
On the calendar 01-OCT-2026
Key points
  • Creates a three-year TBI Innovation Grant Program in which eligible nonprofits, academic institutions, non-VA health providers, and partnerships may receive grants of up to $5 million per fiscal year to test neurorehabilitation treatments for chronic mild TBI.
  • Requires a separate research grant program administered by an independent organization outside the VA, with four exploratory grants of up to $625,000 each and five collaborative grants of up to $1.5 million each per year.
  • Authorizes $10 million per year for each program for fiscal years 2026 through 2028, and lets the VA use existing mental health and PTSD center funds without replacing other department programs.
  • Requires annual reports to Congress and changes the date in the VA housing loan fee table from June 9, 2034 to July 14, 2034.
AI-generated from the Reported in House text of 01-OCT-2026 · verify · report an error
Official CRS summary

No CRS summary yet. CRS writes one for most bills, often months after they move.

CRS is the Library of Congress's nonpartisan research office. Check on congress.gov
Committee referrals (2) Policy area

Armed Forces and National Security

Sponsor Jack Bergman (R-MI) Cosponsors · 13
■ 7 R■ 6 D